NCT06062745 - Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

September 1, 2026

Study Completion Date

September 1, 2028

Conditions

Advanced Prostate CancerMetastatic Prostate CancerMetastatic Prostate Neuroendocrine Carcinoma

Interventions

DRUG

18F-fluciclovine

18F-fluciclovine is a radiotracer targeting amino-acid transporters.Radiotracers are compounds or drugs that are attached to small amounts of a radioactive substance to make images of processes that are happening in the body

DEVICE

PET/CT

Positron emission tomography/computed tomography (PET/CT) uses small amounts of radioactive materials called radiotracers, a special camera and a computer to help evaluate organ and tissue functions.

Trial Locations (2)

02115

RECRUITING

Dana Farber Cancer Institute, Boston

02215

RECRUITING

Brigham and Womens Hospital, Boston